EarningsQ2 2026 Earnings Report
MX:STMNN Q2 2026 EPS Results
Actual EPS$35.64
Consensus EPS$34.99
Beat/MissBeat by +$0.65
One Year Ago EPS$36.08
MX:STMNN Q2 2026 Revenue Results
Actual Revenue$29.98B
Expected Revenue$15.32B
Beat/MissBeat by +$14.66B
YoY Revenue Growth+2.32%
Earnings Announcement Details
QuarterQ2 2026
Date08/19/2026
TimeBefore Open
Conference CallWednesday, August 19, 2026
MX:STMNN Upcoming Earnings
Straumann Holding AG's next earnings date is estimated for October 28, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlighted broad and accelerating commercial momentum (high single-digit organic growth, broad regional contributions), meaningful margin expansion driven by productivity and disciplined OpEx management, strong cash flow generation and rapid uptake of digital solutions and implant platforms. Key near-term headwinds include US tariffs (partly recognized), an FX-related margin drag (~80–100 bps at July spot rates), and regulatory/pricing uncertainty in China (VBP 2.0) plus a small noncore drag. Management confirmed a confident outlook and reiterated medium-term ambitions. On balance the positive operational and financial developments outweigh the challenges, though execution on China/VBP and currency management remain important risks to monitor.Company Guidance
Strong Revenue Growth
Q2 revenue of CHF 707m (organic +8.5%, reported +5.9% in CHF); H1 revenue ~CHF 1.4bn (organic +7.8%, reported +2.3% in CHF). Acceleration from Q1 to Q2 with contributions across all regions.
Regional Outperformance
EMEA organic growth Q2 +8.6% (H1 +8.2%); North America Q2 +8.4% (H1 +8.1%); Asia Pacific Q2 +7.4% (H1 +4.2%) with outside-China Q2 growth +25%; Latin America Q2 +11.8% (H1 +15.4%).
Profitability Improvement and Upgraded Outlook
Core EBIT margin reached 26.9% at constant 2025 FX (25.7% including currency effects). Company confirmed upgraded 2026 outlook: high single-digit organic revenue growth and a core EBIT margin improvement of ~140–170 bps at constant 2025 exchange rates.
Core Gross Profit and Margin Strength
Core gross profit CHF 972m in H1 with core gross margin 70.5%. Productivity and mix contributed +40 bps; underlying gross margin improvement seen when excluding one‑time write-down and tariff effects. IFRS gross margin 72% (includes tariff refunds).
Core Net Profit and Conversion
Core net profit CHF 262m (core net margin 19%); currency-adjusted net profit up +15.7% vs prior year. Improved EBIT drove CHF 38m of the bridge to net profit; IFRS net profit CHF 251m after CHF 11m net noncore items.
Strong Free Cash Flow and Balance Sheet
Free cash flow CHF 169m (+49% YoY), representing 12.2% of net revenue vs 8.4% prior year. Net cash position CHF 350m; cash & equivalents CHF 381m. CapEx reduced to CHF 74m (5.4% of revenue) from CHF 113m prior period.
Digital Solutions and Scanner Traction
Digital solutions (intraoral scanner portfolio led by SIRIOS X3) grew at double-digit rates; connected user base grew at double-digit rates, expanding recurring software and consumables opportunity and strengthening Straumann AXS ecosystem.
Implant Leadership and Challenger Brand Momentum
iEXCEL represented close to 40% of Straumann premium implant volumes in H1 and is driving new account wins; Neodent and Anthogyr scaled in challenger segments (Curitiba capacity expanded) supporting share gains globally.
ClearCorrect Transformation Progress
ClearCorrect commercial and manufacturing improvements driving GP adoption, active case growth and COGS consistency; target to reach breakeven by end-2027.
MX:STMNN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed